What do you consider a standard of care for patients that are mNSCLC PD-L1 non-expressors?
Professor Nir Peled, MD, PhD, FCCP. Director of the Cancer Centre at the Soroka Medical Centre, Ben-Gurion University, Beer-Sheva, Israel
AU-KEY-00712
Professor Nir Peled, MD, PhD, FCCP. Director of the Cancer Centre at the Soroka Medical Centre, Ben-Gurion University, Beer-Sheva, Israel
AU-KEY-00712